Skip to main content
Skip to results
110 updates
About Respiratory disease and allergy
  • Extension of the indication for nicotine replacement therapy (NRT) to include harm reduction.

  • Patients who require a liquid oral formulation of a β-agonist should be switched to a more-selective short-acting β2-agonist such as salbutamol or terbutaline.

  • How to reduce risk of illicit use.

  • Overall benefits of long-acting β-agonists (LABAs) in the treatment of chronic obstructive pulmonary disease (COPD) continue to outweigh any risks.

  • Advice on how to use cough and cold medicines safely for children under 12 years.

  • Licensed doses and differences in potency between different inhaled corticosteroids; advice for use with spacer device.

  • Long-acting β2 agonists (LABA) should only be prescribed in conjunction with inhaled corticosteroids for the treatment of moderate to severe asthma.

  • We have recently advised that talc preparations for pleurodesis are to be considered as medicinal products.

  • To avoid the risk of air embolism, these products should not be infused under pressure.

  • Physicians should remain vigilant for pneumonia and other infections of the lower respiratory tract (ie, bronchitis) in patients with chronic obstructive pulmonary disease who are treated with inhaled products that contain s…